Hydrolysate based infant formula
OtherInfant formula ad lib
NCT Number: NCT01155414
The primary objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental powdered formulas compared with a commercially available powdered formula.
Looking for future studies?
Notify Me1 day–8 day
All sexes
Interventional
Phase 3
Alabama Clinical Therapeutics, LLC, Birmingham, Alabama, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Infant formula ad lib
Investigational infant formula ad lib
Investigational infant formula ad lib
Time frame: 28 days
Abbott Nutrition
Industry
Tolerance of Healthy Term Infants Fed Infant Formulas
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02646969
Healthy Term Infants
Bordeaux, France
View Trial DetailsNCT04015050
Healthy Term Infants
Bialystok, Poland
View Trial DetailsNCT01497314
Growth, Healthy Term Infants
Melbourne, Florida, United States
View Trial DetailsNCT00712608
Healthy Term Infants
Birmingham, Alabama, United States
View Trial Details